Connect with us

Hi, what are you looking for?

Jewish Business News

Business

MyHeritage launches a new DNA kit to provide personalized health diagnoses

The new kit includes reports of various diseases such as Tay-Sachs, Cystic Fibrosis, heart disease, breast cancer, colorectal cancer, and type 2 diabetes

MyHeritage, the Israeli family history and DNA testing, today announced a significant expansion of its genetics activities.

The company has launched a new kit called MyHeritage DNA Health + Ancestry, to provide genetic insights that can improve the health of the users.

The Health + Ancestry report provides a variety of diseases in which a specific gene is a risk factor – monogenic diseases such as hereditary breast cancer and later development of Alzheimer’s disease And Parkinson’s; Recessive hereditary diseases that couples may transmit to their children, such as Tay Sachs and Cystic Fibrosis, and diseases with a complex genetic component – polygenic diseases such as heart disease and type 2 diabetes.

The kit covers a wide range of diseases and includes 11 reports on dominant genetic risk factors, including a report on hereditary breast cancer (BRCA), which examines 10 pathogenic mutations, 15 reports of hereditary diseases and 3 Risks from a complex genetic disease.

The World Health Organization has identified the cardiovascular disease as the number one killer in the world. This makes the MyHeritage report particularly useful, as the user is given a breakdown of the genetic risk of these diseases, based on a new method of machine learning called the Polygenic Risk Score, which examines hundreds, and in some cases Thousands of genetic markers across the entire genome. In addition to heart disease, the kit also includes a similar risk report for type 2 diabetes, a disease that has increased in recent decades and now affects hundreds of millions of people worldwide, including 40% of the US population.

The user is given a breakdown of the genetic risk of these diseases, based on a new method of machine learning called the Polygenic Risk Score, which examines hundreds, and in some cases Thousands of genetic markers across the entire genome.

The new MyHeritage kit also providing a multi-gene report that measures the risk of breast cancer, which provides a risk assessment for breast cancer even when none of the specific BRCA mutations that the assessment is testing is found.

The new product is based on scientific research conducted by Prof. Yaniv Erlich, Chief Scientist of MyHeritage.

Newsletter



Advertisement

You May Also Like

World News

In the 15th Nov 2015 edition of Israel’s good news, the highlights include:   ·         A new Israeli treatment brings hope to relapsed leukemia...

Entertainment

The Movie The Professional is what made Natalie Portman a Lolita.

Travel

After two decades without a rating system in Israel, at the end of 2012 an international tender for hotel rating was published.  Invited to place bids...

VC, Investments

You may not become a millionaire, but there is a lot to learn from George Soros.

Advertisement